Receptors, Tumor Necrosis Factor, Type II
"Receptors, Tumor Necrosis Factor, Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tumor necrosis factor receptor subtype that is expressed primarily in IMMUNE SYSTEM cells. It has specificity for membrane-bound form of TUMOR NECROSIS FACTORS and mediates intracellular-signaling through TNF RECEPTOR ASSOCIATED FACTORS.
| Descriptor ID |
D047889
|
| MeSH Number(s) |
D12.776.543.750.705.852.760.798
|
| Concept/Terms |
Receptors, Tumor Necrosis Factor, Type II- Receptors, Tumor Necrosis Factor, Type II
- Receptors, Tumor Necrosis Factor, Member 1B
- TNF-R2
- TNF-R75
- TNF-RII
- TNFR p75
- Tumor Necrosis Factor Receptor 75
- Tumor Necrosis Factor Receptor 2
- TNFR2
- Tumor Necrosis Factor Receptor Type 2
- Tumor Necrosis Factor Receptor Type II
- Antigens, CD120b
- CD120b Antigens
- TNFRSF1B Receptor
- Receptor, TNFRSF1B
- Tumor Necrosis Factor Receptor Superfamily, Member 1B
- CD 120b Antigen
- 120b Antigen, CD
- Antigen, CD 120b
- CD120b Antigen
- Antigen, CD120b
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Tumor Necrosis Factor, Type II".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Tumor Necrosis Factor, Type II".
This graph shows the total number of publications written about "Receptors, Tumor Necrosis Factor, Type II" by people in this website by year, and whether "Receptors, Tumor Necrosis Factor, Type II" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 1 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2017 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Tumor Necrosis Factor, Type II" by people in Profiles.
-
Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis. Ann Rheum Dis. 2023 08; 82(8):1076-1090.
-
Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-a triggers tumorigenic inflammation in neuroblastoma. J Immunother Cancer. 2023 03; 11(3).
-
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors. J Transl Med. 2022 07 25; 20(1):331.
-
Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research Consortium. Lupus. 2021 Aug; 30(9):1394-1404.
-
TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells. JCI Insight. 2019 12 19; 4(24).
-
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved?Spirometry in SPIROMICS. Chest. 2019 05; 155(5):908-917.
-
Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes. Diabetes Care. 2018 01; 41(1):128-135.
-
Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori. Respir Res. 2017 05 30; 18(1):109.
-
Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2016 09; 68(9):1303-9.
-
Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery Study. J Proteome Res. 2016 07 01; 15(7):2102-14.